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Determining the Relationship between Salivary α-Amylase, Cardiovascular, and 
Hemodynamic changes during the Cold Pressor Test 
 
Marylen Youssef, MSc. 
 
The cold pressor test (CPT) has been long used as an activator of the sympathetic nervous 
system (SNS) but it is not clear if the CPT consistently results in the increases in salivary α-
amylase (sAA), and how the changes in salivary α-amylase are correlated to cardiovascular and 
hemodynamic parameters. Additionally it is not known how individuals can be characterized 
based on these correlations.  
30 healthy participants, 14 males and 16 females, underwent a hand CPT for 5 minutes at 
4°C while having their cardiovascular and hemodynamic parameters monitored and saliva 
sampled. The CPT resulted in changes in most cardiovascular and hemodynamic parameters 
measured, SBP, DBP, MAP, TPR, PEP, LVET, PEP/LVET, dP/dt, and dZ/dtmax. There was no 
significant change in HR, CO, and SV. The CPT caused an increase in salivary α-amylase at the 
end of the 5 minutes, that continued to increase up to 10 minutes post CPT. The change in 
magnitude (Δ) of Δ1 sAA or Δ2 sAA was correlated to the Δ1HR (ρ=0.5, p<0.01) (ρ=0.48, 
p<0.05) respectively. CPT sAA levels were correlated to baseline HR (ρ=0.43, p<0.05) and 
inversely proportional to Δ1SBP (ρ=-0.47,p<0.01) and baseline PEP (ρ=-0.38, p<0.05). 
When grouped based on high (<20mmHg) or low (>20mmHg) systolic response to the 
CPT, low responders had higher resting salivary α-amylase and higher resting HR than the high 
responders suggesting that SNS activity can be characterized using the CPT and salivary α-
amylase measures. While the CPT caused robust changes in salivary α-amylase, the delayed 
increase suggests that other measures such as ΔSBP are better indicators of the SNS response in 
healthy people.  
 
Key Words: Cold pressor test, sympathetic nervous system, salivary α-amylase, blood 
pressure, heart rate, diastolic blood pressure, systolic blood pressure, saliva.  
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ρ: Spearman’s rank correlation coefficient  
Δ1: CPT value – baseline value = mean (t4, t5) – mean (t1, t2, t3) 
Δ2: CPT value – recovery value = mean (t4, t5) – mean (t6, t7) 
α: Alpha  
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All living organisms survive by maintaining a balance in their internal environments, a 
state termed homeostasis. Perturbations to this preferred state of homeostasis are viewed by the 
body as taxing, hence require the body to adapt accordingly in order to re-establish its prior 
balanced state (Elenkov et al. 2000). The autonomic nervous system (ANS) is one of the body’s 
major adaptive systems that unconsciously regulates bodily functions by changing and adjusting 
in response to the environment’s demands. The ANS is made up of two divisions, the 
parasympathetic nervous system (PNS) also known as the “rest and digest” system and the 
sympathetic nervous system (SNS), which is referred to as the “fight or flight” system. (Guyton 
and Hall, 2006). Optimal functioning of these two systems is crucial since they are responsible 
for regulating the body’s internal organs and energy environment.  
One of the most prominent and fastest acting physiological response to homeostatic 
deviations is the activation of the SNS. The SNS causes release of norepinephrine (NE) and 
epinephrine (E) from the adrenal medulla into the circulation acting on adrenergic receptors 
located on the body’s organs and tissues. Fibers from the SNS also directly innervate the tissues 
in most organs, therefore allowing the mediation of neuronal and hormonal responses (Guyton 
and Hall, 2006).  
In order to study the SNS and its integrity, acute non-invasive disruptors of homeostasis 
are often used to evoke a sympathetic response including changes in heart rate (HR), blood 
pressure (BP) and plasma E and NE. The hemodynamic parameters that are influenced by the 
changes in HR and BP such as total peripheral resistance (TPR), mean arterial pressure (MAP), 
cardiac output (CO), stroke volume (SV), peak left ventricular ejection velocity (dZ/dtmax), left 
ventricle contractility (dP/dt) and cardiac sympathetic markers such as pre-ejection period (PEP) 
and left ventricular ejection time (LVET) are also measured to indicate sympathetic activation 
(Newlin et al. 1979; Obrist 1981; Sherwood et al. 1990).  
Most cardiovascular and hemodynamic changes can be measured in a non-invasive 
manner, however NE, a strong indicator of SNS activation, is measured invasively by drawing 
blood. NE cannot be measured alternatively; therefore salivary α-amylase is used as a surrogate 
biomarker for NE and an indicator of SNS activation. Salivary α-amylase is a reliable biomarker 
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for NE and is strongly correlated to plasma NE (r=0.64) but not plasma E (r= 0.49) (Chatterton et 
al. 1996). 
Exposure to cold via the cold pressor test (CPT) is one of the most robust, reliable, and 
repeatable physical activators of the SNS (Hines and Brown.1932; Saab et al. 1993; Sherwood et 
al. 1997; Hassellund et al. 2010; Zhao et al, 2012). The CPT activates the SNS and causes 
increases in plasma norepinephrine levels (Lake et al. 1976). There is increased sympathetic drive 
to the skeletal muscles and organs during the CPT as determined by intra-neural microelectrode 
recordings, which results in increased BP, HR, and plasma NE levels (Rohleder et al. 2006). The 
CPT has a high variability between individuals; it elicits consistent and reproducible responses in 
systolic, diastolic, and HR responses in individuals when repeated measures are made over 
periods of time in those same individual (Hines and Brown, 1932; Saab et al. 1993; Sherwood et 
al. 1997; Hassellund et al. 2010; Zhao et al. 2012). Hines and Brown  proposed that individuals 
could be characterized as high or low SNS responders based on their SBP changes in response to 
the CPT (Hines and Brown, 1932).  
The cardiovascular and hemodynamic responses to the CPT have been well established, 
however the corresponding changes in salivary α-amylase are not well known. Salivary α-
amylase increases during psychological disruptors of homeostasis (Skosnik et al. 2000; Bosch et 
al. 2003; Takai et al. 2004; Rohleder et al. 2004; Nater et al. 2006; Van Stegeren et al. 2008; 
Sánchez-Navarro et al. 2012), but has not been seen to consistently increase with the use of the 
CPT on its own (O’Donnell et al. 2009). Van Stegeren et al, combined the CPT with aversive 
picture viewing that resulted in increases in salivary α-amylase level, however, this outcome may 
have been due to the combination of the two SNS activators (Van Stegeren et al. 2006). To our 
knowledge, the only study known to have measured changes in salivary α-amylase in response to 
the CPT as an SNS activator on its own only included female participants, did not account  for 
menstrual cycle, nor was the consumption of caffeine or other SNS stimulators (O'Donnell et al. 
2009). This was the first study to include both male and female participants, account for 
menstrual cycle, and for possible SNS stimulators and measure salivary α-amylase changes cause 





2.0 Rationale and Objective 
 
2.1 Rational  
 
The purpose of this study was to determine if the CPT causes a robust change in salivary 
α-amylase and whether those changes are directly correlated to the changes in cardiovascular and 
hemodynamic parameters indicative of sympathetic activity. The secondary purpose was to 
characterize participants based on the magnitude of SBP changes in response to the CPT and 
determine if the two groups differ in cardiovascular and hemodynamic parameters or salivary α-
amylase levels.  
To our knowledge there had not yet been a study that had correlated salivary α-amylase to 
cardiovascular and hemodynamic sympathetic markers using the CPT. It is not known if 
magnitude of changes in SBP are correlated to changes in salivary α-amylase levels. This study is 
unique since saliva will be sampled during and immediately after the CPT. The studies that have 
used the CPT as a homeostatic disrupter have not measured salivary α-amylase during and 
immediately after the CPT but collect the first post-CPT saliva sample 5 minutes later, therefore, 
is it unknown what happens during and immediately after the CPT.  
Having a non-invasive way to measure sympathetic activation is necessary in order to 
conduct research in a natural environment. The non-invasive nature of salivary measures are 
valuable since individual differences in the SNS response can be studied in the laboratory as well 
as in a naturalistic setting. Understanding if salivary α-amylase changes are correlated to changes 
in cardiovascular and hemodynamic parameters that are under SNS control will allow for salivary 
α-amylase to be used as a measure on its own indicative of SNS activation or in conjunction with 
other physiological parameters. Salivary α-amylase responses to the CPT could potentially be 
used to classify SNS responsiveness into categories.  
2.2 Objective  
 
 Cause a robust increase in salivary α-amylase using a hand CPT and determine the 
relationship between salivary α-amylase, cardiovascular, and hemodynamic changes during the 
CPT. The secondary objective is to determine if participants can be categorized based on how 





 Cardiovascular and hemodynamic parameters will change in response to the CPT and will 
return to baseline levels during the recovery period following the test.  
 
Hypothesis 2 
Salivary α-amylase levels will increase in response to the CPT and will return to baseline 
levels during the recovery period following the test.  
 
Hypothesis 3 
 The changes in SBP, HR, and other cardiovascular and hemodynamic parameters derived 
from these changes will be directly correlated to the changes in salivary α-amylase induced by 




Perform the CPT on 30 healthy participants (male and female) and measure 









 impedance cardiograph before, during, and after the CPT.  
Aim 2 
Collect saliva from the same 30 healthy participants before, during, and after the CPT and 
use an α-amylase kinetic reaction kit to measure the levels of salivary α-amylase.  
 
Aim 3  
  
  Use Spearman’s rank correlation coefficient to determine statistical dependence between 
α-amylase and the cardiovascular and hemodynamic changes induced by the CPT. Categorize 
participants as high (>20mmHg) or low (<20mmHg) systolic blood pressure responders and 






 A total of 32 healthy participants were recruited, 16 males and 16 females. Only 14 males 
were included since 2 males participants did not complete the study. The mean age of the 
participants was 24.7 years (SD= 4.9years). The mean age of female participants was 22.6 years 
(SD= 2.6 years), mean weight was 65.1 kg (SD= 12.1 kg), and mean height was 164.7 cm (SD= 
6.2 cm). The mean age for male participants was 27.2 years (SD= 5.8), mean weight was 83.0 kg 
(SD= 17.2 kg), and mean height was 176.3 cm (SD= 7.3 cm). Participants were recruited through 
word of mouth, social media, e-mail, and a flyer sent out by PERFORM. Only healthy 
participants were included. Healthy was defined as anyone who did not self-report a known 
disease or any previous history of disease such as cardiovascular disorders, neurological 
disorders, diabetes, epilepsy, known hypertension, or Raynaud’s syndrome. Individuals who were 
either pregnant or smokers were excluded. Anyone taking medications that altered cardiovascular 
function (e.g. beta-blockers, antidepressants) or who reported taking recreational drugs were also 
excluded.   
Menstrual cycle was determined for female participants prior to their scheduling and 
participation by self-reporting. They were scheduled during the follicular phase of their menstrual 
cycle; this was done by asking them when their last period finished. All participants were 
scheduled no later than seven days after the cessation of their last period.  
 Participants had the option of being scheduled for participation at 9:30am, 11:30am, 
1:30pm and 3:30pm. Participants were not scheduled later than 3:30pm due to the presence of a 
diurnal rhythm in salivary α-amylase secretion (Nater et al. 2007; Rohleder et al. 2004). They 
were given pre-participation instructions stating they had to abstain from caffeine, exercise, and 
alcohol consumption 12 hours prior to participation, in addition to abstain from eating at least 2 
hours before participation. Ethics was reviewed and approved by University Human Research 
Ethics Committee (UHREC) at Concordia University. All participants  provided informed 
consent and were  compensated with a gift card.  
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5.2 Procedure  
  
 On the day of the study, participants presented themselves at the Concordia University 
PERFORM Centre. Each participation session lasted approximately 1.5 hours. Setting 
participants up with the equipment took 45 minutes and the experimental recording time lasted 32 
minutes.  
Upon arrival, participants signed the consent form, were given an explanation of the study 
procedure in addition to being shown the equipment they would be set-up with. Prior to 
participation, a series of questions were answered and participant’s height and weight was 
measured. They answered questions about their age, sex, how long ago they last ate, when they 
woke up, how the quality of their sleep was and what mode of transportation they had used to get 
to the PERFORM Centre. Females confirmed that they had finished their last period not more 
than 7 days ago. Participants were also asked to confirm that they had followed all of the pre-
participation instructions before being set-up with recording equipment. Participants were then 










 Figure 1.is a schematic of the study procedure. After the Nexfin
®
 was calibrated, the 
“Start” button was selected in the COP_WIN™ software, and the timer was started (t0), these two 
pieces of equipment ran continuously throughout the study. At the baseline time points 5 (t1), 10 





the blood pressure was being read, the saliva sample was collected from the participant. 
Participants pooled their saliva in their mouths 2.5 minutes prior to collection during baseline. 
After the third baseline measure was collected (t3), a 2minute window was allotted to give the 
researcher time to retrieve the cooler containing the ice cold water and position it next to the 
participant. A towel was placed on the participants lap in preparation for when the hand would be 
removed from the water. Participants were reminded that they could withdraw their hand from 
the cold water at any time and would not be penalized for having done so, and would 
unconditionally be compensated for their participation.  
At the end of the 2 minute window, the participants were instructed to submerge their 
hand into the water bath up to wrist level for 5 minutes. They were also instructed to not swallow 
or make chewing motions, but to have the saliva passively pool. They had to keep their hand in a 
passive open position. 2.5 minutes into the CPT (t4) and at the end of the CPT (t5), blood pressure 
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 and saliva samples 
were collected. The participant’s hand was removed from the cold water and wrapped in the 
towel. They rated the pain they had felt on a scale of 0 to 10 using a visual analog scale (0= no 
pain to 10= most painful) at three different time points; 10 seconds after they had submerged 
their hand in the cold water, halfway through the CPT (t4) and right before they took their hand 
out of the cold water (t5).  
BP, HR measures, and saliva samples were collected 5 minutes (t6) after the CPT and 10 
minutes (t6) after the CPT. This period was identified as the recovery period.  
 
Figure 1. Schematic of Study Procedure 
 
 
Note: Schematic of CPT procedure and data collected over time. The CPT is represented by the blue color. At t0 = 
participant is ready for measurement. Baseline is represented by: t1= Baseline 1 (5 minutes after t0), t2= Baseline 2 
(10 minutes after t0), t3= Baseline 3 (15 minutes after t0). After t3 there was a 2minute window to prepare water bath. 
t4= 2.5 minutes into the CPT, t5= 5 minutes mark of CPT. The recovery time points are represented by t6= Recovery 





5.3 Cold Pressor Test   
 
  The CPT was done in an ice-cold water bath (4°C), which was monitored using a 
standard mercury thermometer. A cooler was used as the vessel for the water bath and the 
temperature was maintained at 4°C by having ice packs covering all walls (except the side 
adjacent to the participant) and bottom of the cooler. The mean water temperature for all 
participants was 3.3°C (SD= 0.8°C). The right hand was submerged to wrist level and was left in 
the water for 5 minutes for all participants. If they took out their hand earlier they were excluded 
from the study results.  
5.4 Cardiovascular Measurements  
 





measurements were initiated manually 45 seconds before the desired measurement time point. 
For each of the measurements, systolic blood pressure (SBP), diastolic blood pressure (SBP), and 
hear rate (HR) values were recorded.  
 The Nexfin
®
 beat-to-beat hemodynamic monitoring system was used to continuously 
monitor SBP, DBP, HR, mean arterial pressure (MAP), systemic vascular resistance (SVR), 
cardiac output (CO), stroke volume (SV), and left ventricle contractility (dP/dt). 30second 
averages were used for all values provided by the Nexfin
®
. Reports were created and exported as 
PDF files from the Nexfin
®
 monitor onto a USB. Participants were setting according to the 
procedure-operating document “Use and Cleaning of Nexfin”. 
 Continuos cardiodynamic activity was recorded using impedance cardiography (ICG) 
using electrode bands in full band configuration (Bacon et al, 2010; Sherwood et al., 1990). The 
ICG signal was recorded using the HIC-4000I
®
 impedance cardiograph, in addition to the 
COP_WIN/HRV™ software (Bio-Impedance Technology, Inc., Chapel Hill, NC). The 
impedance cardiograph was used to continuously record HR, CO, SV, PEP, LVET, PEP/LVET, 
and dZ/dtmax. Participants were set-up according to the procedure-operating document “Use and 
Cleaning of HIC-4000I impedance cardiograph”. The signal was picked up using 4 disposable 
mylar band electrodes (T8001 Bio-Impedance Technology, Inc., Chapel Hill, NC). The first 
“recording” electrode was placed around the base of the neck and the second was placed around 
the thorax at the level of the xiphoid process. The “current” electrodes where placed at least 3cm 
below and parallel to the “recording electrodes”. The distance between the two “recording” 
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electrodes in cm in the front  (parallel to the sternum) and the back (parallel to the spine) were 
recorded, and averaged by the COP_WIN/HRV™ software. Data was collected continuously 
using 30 second ensemble averages (EA) and a 60 Hz filter.  
5.5 Salivary α-Amylase in Measurements  
 
Participants pooled saliva between their tongue and pallet instead of actively salivating, 
chewing or swallowing, to ensure that they were not stimulating the secretion of salivary α-
amylase. Saliva was collected at the indicated time points (t1 to t7) using a sealed sterile transfer 
pipette inserted between the tongue and palette collecting the accumulated saliva. Samples were 
transferred and stored in 1.5ml micro-centrifuge tubes. Roughly 0.5ml of saliva was collected 
from each participant. Saliva was weighed and divided into 20μl labeled aliquots before being 
frozen at -20°C until needed for analysis.  
Before analyzing the samples, they were thawed and centrifuged at 1500x g for 15 
minutes. Samples were analyzed for salivary α-amylase using an α-amylase kinetic reaction kit 
(1-1902, (Single) 96-Well Kit, Salimetrics Inc, Carlsbad, CA). The protocol provided by the 
manufacturer was followed. In brief, a 1:10 dilution was made by mixing 10μl of each saliva 
sample with 90μl of diluent. The sample was further diluted to a 1:200 dilution by adding 10μl of 
the 1:10 to 190μl of diluent. 8μl of the pre-diluted controls (high and low salivary α-amylase) and 
the 1:200 saliva dilutions were plated onto a 96-well plate. Samples were plated in duplicate. 
300μl of α-amylase substrate pre-heated at 37°C was added to the plate, one row at a time and 
was read through a 405nm filter. Readings were taken at 1 and 3 minutes, time point 3 was 
subtracted from time point 1 and multiplied by 328 to get the activity measure of salivary α-
amylase in Units per milliliters (U/ml).  












at the 7 different time points were averaged for the 30 participants. This resulted in the average 










 provided values for every 30 seconds throughout the 32 minute time span of 
the study. The raw data was transferred into an excel file and binned; resulting in a value that was 
representative of each of the 7 time points. The first 5, 10, and 15 minutes were each averaged 
and represented baseline time points t1, t2, and t3 respectively. The data representing the two 
minutes allotted to retrieving the water bath were removed completely from the data. The first 2.5 
minutes of the CPT were binned to represent time point t4, and the second 2.5minutes represented 
time point t5. The data collected during the first 5 and 10 minutes of the recovery period were 
binned individually to represent the recovery time point t6 and t7. The binned data from the 
Nexfin
® 
was used for 29 of the 30 participants. 1 female participant was excluded since the 
Nexfin
®
 readings were not recorded due to her having cold hands. Since Nexfin
®
 makes its 
reading based on finger pulse pressure, if the participant’s hand are too cold and cannot be 
warmed up, the measurements are not recorded since the system is unable to calibrate and make 
reading accordingly.  
5.6.3 Cardiac Impedance 
 
Before retrieving data from the impedance cardiograph and creating reports for each of 
the participants, the data was manually cleaned by adjusting the B-wave point using the B-cursor 
edit tool option in the COP_WIN™ software. In some cases the B-point had to be shifted 
manually to the beginning point of the rapid upslope of the dZ/dt waveform as it climbs to reach 
the peak, because the original recording had not identified it correctly. 30second ensemble 
averages (EA) were used, therefore data was present for every 30 seconds of time elapsed. Once 
every file was cleaned, the data was averaged in the same way as the data from the Nexfin
®
. The 
data was binned for 27 participants out of 30.Three participants were excluded since the data was 
not recorded due to recording errors.  
5.6.4 Salivary α-Amylase  
 
 Baseline salivary α-amylase values at t1, t2, and t3 were averaged from the 30 participants, 
and all 7 values were divided by the average obtained to produce a corrected (fold change value) 
in some graphs. For all analyses involving salivary α-amylase 1 participant had to be excluded 
since values were more than 3 standard deviations higher than the mean.  
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 An un-paired two-tailed t-test was used to compare all baseline measures between men 
and women using GraphPad Prism, version 5.01 for windows. A 95% confidence interval was 
used for all t-tests; they were all computed using GraphPad Prism (GraphPad Prism, version 5.01 
for windows, Graphpad Software, Inc. 2007).  
5.7.2 Calculating Delta Values (Δ1 and Δ2) 
 
 Once baseline, CPT, and recovery averages were computed for salivary α-amylase, and 
all hemodynamic and cardiovascular parameters, Δ1 and Δ2 were calculated Δ1 was the CPT –
baseline and Δ2 was calculated recovery - CPT. Deltas were used to determine the magnitude of 
change in each parameter. All delta calculations were done on Microsoft excel.  
5.7.3 Spearman’s Correlation Coefficient 
 
Spearman’s correlation coefficient was used to measure statistical dependence between 
two variables. Salivary α-amylase levels at baseline, CPT, recovery, in addition to the delta 
salivary α-amylase values were correlated to cardiovascular and hemodynamic parameters that 
reflect sympathetic activity. A 95% confidence interval was used. The table shows the ρ-value in 
addition to the p-value. GraphPad Prism was used (GraphPad Prism, version 5.01 for windows, 
Graphpad Software, Inc. 2007).  
 
5.7.4 Repeated Measures ANOVA 
 
 A repeated measures one way ANOVA was used to determine if there was a significant 
difference in α-amylase levels and the cardiovascular and hemodynamic parameters measured at 
three different periods; baseline (average t1,t2,t3), CPT (average t4,t5) and recovery (average t5,t6). 
A p-value <0.05 was used for the analysis (GraphPad Prism, version 5.01 for windows, Graphpad 
Software, Inc. 2007). Tukey’s post hoc test was used to determine which of the three groups were 
different.   
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6.0 Results  
 
6.1 Baseline Parameters 
 
A total of 30 healthy participants, 14 of which were women, and 16 men were recruited 
and completed the test. Their characteristics are presented in Table 1. Two of the initial 16 male 
participants were excluded since they both withdrew their hands from the water pre-maturely 
during the CPT. The average age of participants recruited was 24.7 years (SD= 4.9 years). The 
baseline parameters between men and women were compared using an unpaired two-tailed t-test 
and a 95% confidence interval. Male participants were older (p<0.05), taller (p<0.001), and 
heavier (p<0.01) than female participants. At baseline, male participants had higher resting SBP 
(p<0.001), DBP (p<0.001), MAP (p<0.05), and SV (p<0.001). Female participants had a 
significantly higher HR (p<0.001) and dZ/dtmax (p<0.001). There was no difference in CO, PEP, 
LVET, PEP/LVET, dP/dt, and calculated TPR at baseline between men and women. Baseline 
salivary α-amylase did not differ between men and women (Table 1.).  
Table 1. Physical and Baseline Characteristics of Participants  
 
 
Total Mean (SD)  Male n=14 (SD) Female n=16 (SD) 
Age (yrs)   24.7 (4.9)   27.2 (5.8)
*   22.6 (2.6) 
Height (cm) 170.1 (8.9) 176.4 (7.3)
*** 164.7 (6.2) 
Weight (kg)    73.4 (17.1)   83.0 (17.2)
**   65.1 (12.1) 
SBP (mmHg)  117 (15) 124 (13)
*** 111 (13.4) 
DBP (mmHg)    73 (10)   77 (10)
***    68 (8) 
HR (Bpm)    70 (10)   65 (9)
***     74 (9) 
MAP (mmHg)    97 (12) 100 (14)
*    94 (8) 
CO (ml/min)       6.6 (1.1)      6.5 (1.1)      6.7 (1.1) 
SV (ml)     95 (14) 101 (14)
***    89 (11) 
PEP (ms)   133 (13) 133 (10) 132 (15) 
LVET (ms)  276 (20) 275 (21) 277 (20) 
PEP/LVET  0.48 (0.06)      0.49 (0.06)     0.477 (0.06) 
dP/dt (mmHg/s) 1046 (204) 1077 (218) 1018 (186) 
dZ/dtmax (Ω·s-1)  2.17 (0.57)      1.65 (0.28)*** 2.58 (0.37) 
TPR mmHgminml-1 15.3 (4.5) 14.5 (2.8) 16.2 (5.8) 
α-Amylase 
(Units/ml) 
128.9 (114.7)  132.5 (145.2) 125.8 (79.7) 
 
*p < 0.05 , ** p < 0.01, *** p < 0.001 p-value for un-paired two-tailed t-test between men and women. 
SD= Standard Deviation   
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7.2 Effect of CPT on Cardiovascular and Hemodynamic Parameters 
 
A repeated measures one way ANOVA followed by a post hoc Tukey’s test was used to 
compare baseline, CPT, and recovery values to determine the effects the CPT had on the 
cardiovascular and hemodynamic parameters measured. The CPT caused and increase in SBP 





 and the Nexfin
®
. BP changed in the same way using the two devices. There was 
an upward trend of HR during the CPT as compared to baseline values. Figure 3. shows the 
upward trend in HR during the CPT. Again, this upward trend was the same when recorded by 
three different devices simultaneously. In addition to increasing blood pressure, the CPT caused 
an increase in the supplementary cardiovascular and hemodynamic measures influenced by 
changes in blood pressure and sympathetic activation: MAP (p<0.001), dP/dt (p<0.001), LVET 
(p<0.05), dZ/dtMax (p<0.001), and TPR (p<0.001) all increased  (Figure 4, Table 2.). As 
expected with SNS activation through cold exposure, PEP a cardiac marker of SNS activation 
decreased (p<0.01) resulting in a decrease in PEP/LVET (p<0.001) during the CPT when 
compared to baseline. There was no change in CO and SV (Table 2.).  
Both SBP and DBP recovery values were higher than baseline (p<0.001). HR was higher 
during the CPT than it was during the recovery period (p<0.001) and recovery values were lower 
than those measured at baseline (p<0.001). The supplementary cardiovascular and hemodynamic 
parameters MAP, SVR, dP/dt, LVET, dZ/dtMax and calculated TPR (TPR=MAP/CO) remained 
elevated during the 10 minute recovery phase when compared to baseline. PEP remained below 
baseline levels after 10 minutes (p<0.05) and consequently so did PEP/LVET (p<0.001). Table 2. 
shows all values calculated at baseline, during the CPT, and recovery in addition to the delta (Δ1 









Figure 2. Hemodynamic Changes during CPT 
 














































































































throughout the study. Graph B and E represent the blood pressure measured by the Nexfin
®
. 
Graph C represents MAP as measures by Nexfin
®
. Graph F is the calculated TPR. A repeated 
measure one way with p<0.05 was used to determine differences between the 7 time points. Bars 












Figure 3. Heart Rate Changes during CPT 
 


















































. Graph B is the 
heart rate measured by the Nexfin
®
. Graph C is the heart rate measured using HIC-4000I
®
 
Impedance Cardiography.  A repeated measure one way ANOVA with p<0.05 was used to 








Figure 4. Supplementary Hemodynamic Changes during CPT 
 









































































































































Figure 4. Graphs A, D, and G were measured using the Nexfin
®
. Graphs B, C, E, F, H, and I 
were measured using the HIC-4000I
®
 impedance cardiograph. A repeated measure  one way 













Table 2. The cardiovascular and hemodynamic parameters measured during the seven time 
points were averaged during baseline (mean t1, t2, t3), CPT (mean t4, t5), and recovery (mean t6, 
t7). The changes (Δ) in these parameters were calculated by subtracting. Δ1=  (mean CPT –mean 
baseline) and Δ2 = (mean recovery-mean CPT) 
S






= Value measured by HIC-4000I
®
 Impedance Cardiograph  
N
= Value measured by Nexfin
® 
Repeated measure one ANOVA p<0.05 and post hoc Tukey’s Test  
*p < 0.05 , ** p < 0.01, *** p < 0.001 for mean baseline vs.mean CPT 
≠




p < 0.001 for mean CPT vs. mean Recovery 
§
p < 0.05 , 
§§
p < 0.01, 
§§§



















7.3 Effect of CPT on Salivary α-Amylase 
  
Since salivary α-amylase levels vary largely between individuals, values were corrected 
by averaging the 3 baseline values, and then dividing each of the 7 values by the average 
obtained. The corrected salivary α-amylase changed over the 7 time points (Figure 5.). 
Baseline salivary α-amylase values varied largely between individuals and this difference was not 
attributed to sex (Table 1.). When uncorrected salivary α-amylase levels during the CPT were 
compared to baseline there was no difference, only an upward trend was seen (paired two-tailed 
t-test, 95% confidence interval). During CPT levels of salivary α-amylase were only 16 U/mL 
higher than baseline, which is likely why there was no statistical difference calculated. However, 
when the during CPT values were compared to recovery there was a difference (p<.001), with 
recovery values were 33 U/mL higher than CPT values. Values did not return to baseline during 
the recovery period but continued increasing 10 minutes post CPT during the recovery period. 
Levels of salivary α-amylase were higher at recovery (177 U/mL) than at baseline (128 U/mL) by 
49 U/mL (p<.001) (Table 2). 
The changes in salivary α-amylase experienced by men and women throughout the study 
were compared using an un-paired two-tailed t-test and a 95% confidence interval. No difference 
between these two groups was observed at any of the 7 time points. 
Figure 5. Effect of CPT on Salivary α-Amylase 
































Figure 5. Graph A demonstrates the compiled raw salivary α-amylase over time. Graph B represents the corrected 
salivary α-amylase level. 
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7.2 Salivary α-Amylase Correlations  
 
 To determine if salivary α-amylase was associated with the cardiovascular and 
hemodynamic response elicited, the mean CPT, baseline, recovery, Δ1 values (CPT – baseline), 
and Δ2 values (recovery - CPT) for salivary α-amylase were correlated to baseline and Δ1 values 
for 5 selected parameters. The parameters chosen were HR, SBP, PEP, PEP/LVET, and 
calculated TPR. The statistical dependence between these variables was determined by the 
Spearman’s correlation coefficient (ρ). A nonparametric correlation was used, and the p-value 
was calculated using a two-tailed test and A 95% confidence interval. The Spearman correlation 
coefficient (ρ) and the corresponding p-values is presented in Table 3 and Table 4.Baseline HR 
was correlated to baseline salivary α-amylase (ρ= .43, p<0.05), CPT salivary α-amylase (ρ= .43, 
p<0.05), and recovery salivary α-amylase levels (ρ= .44, p<0.05), however was not correlated to 
the Δ1sAA or Δ2sAA values . The Δ1HRwas the only parameter correlated to Δ1sAA (ρ=0.5, 
p<0.01) and Δ2sAA (ρ=0.48, p<0.05)(Table 4.).  
TheΔ1SBP was inversely correlated to baseline sAA (ρ= -.55, p<0.01), CPT sAA (ρ= -
.47, p<0.01), and recovery sAA (ρ= -.44, p<0.05). This indicates that individuals with lower 
salivary α-amylase levels at baseline, during the CPT, and recovery had a greater increase in SBP 
during the CPT than those who had higher salivary α-amylase levels. ΔTPR was also inversely 
correlated to baseline sAA  
(ρ= -0.50, p<0.01) but was not correlated to CPT sAA and recovery sAA.  
Baseline PEP (ρ= -0.38, p<0.05), was inversely proportional to CPT sAA. Therefore the 
higher an individuals baseline PEP, the lower the CPT sAA levels are. 
In summary, knowing baseline HR, one can have an idea of what an individual’s sAA 
levels are at rest, during the CPT, and recovery. The magnitude of change in salivary α-amylase 
during the CPT, when compared to baseline and recovery, cannot be predicted by baseline HR. 
The only predictor of Δ1 sAA and Δ2 sAA is the Δ1 HR. Thus, the extent to which a person's HR 





Table 3. Salivary α-Amylase Correlations to Cardiovascular and Hemodynamic Parameters 
 
  Base sAA CPT sAA Recovery sAA 
  ρ p-value ρ p-value ρ p-value 
Base HR 0.43 p<0.05 0.43 p<0.05 0.44 p<0.05 
Δ1 HR -0.31 0.097 0.12 0.541 -0.09 0.631 
Base SBP 0.06 0.770 0.23 0.225 -0.01 0.940 
Δ1 SBP -0.55 p<0.01 -0.47 p<0.01 -0.44 p<.0.05 
Base PEP -0.23 0.256 -0.38 p<0.05 -0.31 0.117 
Δ1 PEP -0.05 0.809 -0.05 0.800 -0.09 0.669 
Base PEP/LVET 0.09 0.654 -0.07 0.713 0.02 0.935 
Δ1 PEP/LVET 0.08 0.709 -0.03 0.898 -0.03 0.869 
Base TPR -0.26 0.176 -0.23 0.244 -0.21 0.282 
Δ1 TPR -0.50 p<0.01 -0.21 0.284 -0.22 0.252 
 
Note: Spearman Correlation, 95% confidence interval, two-tailed. 
Δ1= (CPT- Baseline) 
Δ2= (CPT-Recovery)  
Table 4. Delta Salivary α-Amylase Correlations to Cardiovascular and Hemodynamic Parameters 
 
 
  Δ1 sAA Δ2 sAA 
  ρ p-value ρ p-value 
Base HR -0.04 0.818 -0.04 0.840 
Δ1 HR 0.5 p<0.01 0.48 p<0.05 
Base SBP 0.18 0.348 -0.29 0.134 
Δ1 SBP -0.03 0.889 -0.10 0.621 
Base PEP -0.21 0.296 0.09 0.665 
Δ1 PEP -0.01 0.945 0.01 0.977 
Base PEP/LVET -0.24 0.225 0.14 0.485 
Δ1 PEP/LVET -0.06 0.748 -0.19 0.347 
Base TPR -0.02 0.939 0.08 0.682 
Δ1 TPR 0.22 0.261 -0.08 0.674 
 
Note: Spearman Correlation, 95% confidence interval, two-tailed. 




7.3 Characterization of Participants Based on Systolic Response to the CPT 
 
 To determine if participants could be characterized based on their hemodynamic response 
to the CPT, participants were divided into two groups depending on how their SBP changed 
based on the cutoff point suggested by Hines and Brown of a ΔSBP of 20mM. When plotting the 
magnitude of change in SBP in response to the CPT, there was a clear separation between 
participants who responded with a Δ1SBP of low magnitude, and those that had increases in 
Δ1SBP of high magnitude (Figure 6).  Participants with a Δ1SBP of 20mmHg or less were 
characterised as low responders and those with a Δ1SBP of 20mmHg and greater were high 
responders. No participants had a Δ1SBP between 19.5mmHg and 27.5mmHg. These groups 
were statistically different (p<0.001). When grouped in this fashion, there was no difference 
between low or high responders’ CPT-induced changes in salivary α-amylase.  However, there 
was a difference in the resting level of salivary α-amylase levels, with an average of 165 U/mL in 
the low CPT-responders, and only 64 U/mL in the high CPT-responders (p<0.01). This was 
accompanied by a difference in the resting HR: 73bpm in the low CPT-responders, and 64bpm in 
the high CPT-responders, (p<0.01). Thus, people who had a low response to the CPT had 
substantially higher resting salivary α-amylase (+100 units) and HR (+10 bpm) compared to 






























The primary objective of this study was to determine the relationship between salivary α-
amylase, cardiovascular, and hemodynamic changes induced by the CPT, a homeostatic deviator 
and SNS activator. The secondary objective was to determine if individuals could be categorized 
based on how they respond to the CPT.  
The CPT was done  on 30 healthy participants and collecting data about cardiovascular, 
hemodynamic, and salivary α-amylase changes throughout the test. This data was then complied 
to represent 7 different time points. The main question was do salivary α-amylase changes 
induced by the CPT correlate to changes in hemodynamic parameters, specifically changes in 
SBP and measures derived from blood pressure . 
Males had higher resting SBP and DBP than the female participants. This was expected 
since males are known to have higher resting blood pressure than females (Wexler and 
Greenberg, 1978; Kilgour and Carvalho, 1993;). Males also had higher resting MAP since MAP 
is a function of arterial pressure. Female participants had only one baseline measure that was 
higher than the male participants, resting HR. This explains the higher resting SV in males when 
compared to females (SV= CO/HR). Since there was no sex difference in CO at rest, according to 
the equation for SV, a lower HR would yield a higher SV if CO remains unchanged. There was 
also no sex difference for resting levels of salivary α-amylase . 
 In this study, the CPT induced rapid cardiovascular changes, specifically, increases in 
SBP and DBP were observed. These findings are consistent with previous studies (Hines and 
Brown. 1933; Briggs and Oerting.1933; Menkes et al. 1989; McLean et al. 1992; Mishra et al. 
2012). This increase is mostly attributed to the rise in systemic vascular resistance (Cuddy et al. 
1966) justifying the increase in TPR and MAP caused by the CPT. Increases in TPR and MAP 
followed the same pattern as that of SBP and DBP plateauing during the CPT (t4 and t5). SBP, 
DBP, MAP, and TPR peaked during the CPT and decreased during recovery, but did not return 
back to baseline levels. 10 minutes of recovery was not long enough for SBP, DBP, MAP and 
TRP to go back to homeostatic levels.  These findings suggest that the body requires more than 
10 minutes, even after an acute disrupter of homeostasis to re-establish resting states.  
HR did not increase, however, there was an upward trend when the HR during the CPT 
was compared to baseline (Weise et al. 1993, Bacon et al. 2010). Most participants’ HR did not 
increase , but only by 2-3 beats per minute (bpm). . The upward trend in HR was consistent using 
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all three measuring devices. The upward trend could be attributed to the few participants who did 
experience a pronounced increase in HR. Past studies have reported conflicting findings in 
regards to how HR changes in response to the CPT. Some studies have seen robust changes in 
HR (Hines and Brown., 1936; Kilgour and Carvalho, 1993; Bacon et al., 2006), while others 
observed only very small changes in HR (Weise et al, 1993). It was surprising that we did not 
observe larger HR changes with the CPT. This could be explained by the baroreceptors in the 
aorta, which can sense blood pressure, and then send information to the vagus nerve into the 
cardiac center, which in turn tells the HR to decrease. This reflex ensures that HR and blood 
pressure do not simultaneously increase.  
Since blood pressure increased significantly with the CPT, it was expected that the rate of 
left ventricular pressure (dP/dt) increased. LVET increased and peak ejection velocity from the 
left ventricle (dZ/dt) also increased. These findings were collected using the HIC-4000I®, which 
measures electrical impedance changes in the thoracic cavity. These changes are largely 
dependent on the movement of blood in the thorax. The largest contributor is the blood that is 
pumped vigorously by the left ventricle into the aorta with every heartbeat when there is 
increased sympathetic drive to the muscle.  
PEP, a cardiac marker of sympathetic activity changed in response to the CPT. PEP is a 
measure of beta-adrenergic influences on the heart and is primarily controlled by beta-adrenergic 
sympathetic influences on the left ventricle (Newlin et al. 1979; Obrist, 1981; Sherwood et al. 
1990). During homeostatic disruptions where the sympathetic drive pre-dominates, PEP is 
inversely proportional to plasma concentrations of NE (McCubbin et al. 1983). The decrease in 
PEP remained below baseline 10 minutes post CPT, suggesting the sympathetic innervation to 
the left ventricle remained higher than at baseline. These results support the first hypothesis, 
since we expected the measured cardiovascular and hemodynamic parameters to change in 
response to the CPT, however HR did not, which explains the unchanged CO and SV in response 
to CPT.  
The cardiovascular values that were collected using the Nexfin
®
 were slightly higher than 




 and the HIC-4000I
®
. This was expected because Nexfin
®
 
has been validated as an accurate and reproducible monitor for hemodynamic parameters, 
however it is known that the values are over-estimated since Nexfin
® 
measures blood pressure 
based on finger arterial pulse contour analysis (Ameloot, Koen et al. 2015).   
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 The second hypothesis was that the CPT would cause increases in salivary α-amylase. 
Psychological disruptors of homeostasis that elicit robust increases in salivary α-amylase include 
Trier Social Stress Test (Rohleder et al. 2004; Nater et al. 2005) and exposure to aversive pictures 
and video games (Skosnik et al. 2000; Bosch et al. 2003; Takai et al. 2004, 2007; Van Stegeren et 
al. 2008; Sánchez-Navarro et al. 2012). The CPT, which is not a psychological disruptor per say, 
also resulted in robust increases in salivary α-amylase. CPT may induce perceptions of pain, 
however one limitation of this study is that affective response to the CPT of individuals was not 
measured.Changes in salivary α-amylase where not correlated with perceived pain scores (data 
not shown).  
The level of salivary α-amylase did not peak during the CPT but reached the highest 
observed level 10 minutes post CPT. Data was not collected more than 10 minutes after the CPT 
therefore it is not known when salivary α-amylase actually peak.   The increase in blood pressure 
induced by the CPT is due to increased sympathetic drive to the skeletal muscles during the CPT 
as determined by intra-neural microelectrode recordings, which consequently results in increased 
blood pressure (Yamamoto et al. 1992; Rohledr et al. 2006). It seems that the sympathetic drive 
to the salivary glands does not act as rapidly as the drive to the skeletal muscle, since the increase 
in salivary α-amylase only started at the end of the CPT. When the hand is submerged into cold 
water, the input about the cold is relayed via afferent neurons from the periphery through sensory 
endings on the skin to the spinal cord up through the brainstem and into the hypothalamus. Nerve 
impulses are then relayed to pre-ganglionic sympathetic neurons synapsing with post-ganglionic 
sympathetic neurons which are adrenergic therefore NE releasing, innervating the smooth muscle 
of the vasculature increasing arterial pressure. The post-ganglionic sympathetic neurons also 
synapse with the adrenal medulla causing the release of NE, increasing plasma levels of NE 
(Guyton et Hall, 2006; Loewy, 1990). Thus, it may take longer for these changes to elicit amyalse 
activity as compared to an increase in TPR.  
The third hypothesis was that the changes in SBP, HR, and other cardiovascular and 
hemodynamic parameters derived from these changes would be directly correlated to the changes 
in salivary α-amylase induced by the CPT. The reasoning behind this hypothesis was that if the 
CPT is an activator of the SNS and salivary α-amylase directly reflects SNS activity, then the 
cardiovascular and hemodynamic changes caused by the CPT would have matched the changes in 
salivary α-amylase.  
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Surprisingly, the magnitude of change in SBP (Δ1SBP) was not directly correlated to the 
magnitude of change in salivary α-amylase (Δ1sAA). Both SBP and sAA increased due to the 
CPT but they did not increase at the same time. SBP was highest during the CPT but sAA 
reached the highest observed levels 10 minutes after the CPT indicating that the sympathetic 
innervation of the vasculature does not happen in the same way as the sympathetic innervation of 
the salivary gland. The delay of the salivary α-amylase would indicate that salivary α-amylase is 
indeed reflective of plasma NE levels, since circulating levels of NE do not increase immediately 
upon sympathetic activation.  
Baseline HR was correlated to several parameters including baseline, CPT, and recovery 
salivary α-amylase. Baseline HR was not correlated to the Δ1sAAor Δ2sAA). The Δ1HR was the 
only parameter correlated to Δ1sAA  and Δ2sAA . Even though the Δ1HR was not statistically 
significant, the magnitude of that change is correlated to Δ1sAA and Δ2sAA.  
The Δ1SBP was inversely correlated to baseline sAA, CPT sAA, and recovery sAA. This 
indicates that individuals with lower salivary α-amylase levels at baseline, during the CPT, and 
recovery had a greater increase in SBP during the CPT from baseline than those who had higher 
salivary α-amylase levels. 
Tthere was a clear separation between high and low responders when participants were 
divided into categories based on how their SBP changed during the CPT that was consistent with 
the Hines-Brown cutoffs. Changes less than 20mmHg SBP characterized low responders and 
20mmHg changes were those characterized as high responders (p<0.001). Interestingly, 
participants characterized as low responders had higher resting HR values and higher salivary α-
amylase levels than high responders.There was no correlation between changes in salivary α-
amylase levels and the time of day the study was conducted, the water temperature, the age, 
weight, or sex of the participant (data not shown).  
One limitation of the study is that the male participants recruited were older, heavier, and 
taller than the female participants. Another limitation was that the recovery period only lasted 10 
minutes. Moreover, the timepoints were limiting in that salivary α-amylase did not return to 
baseline levels after 10 minutes. Future studies can explore this by extending the time.  
The purpose of this work was to determine if salivary α-amylase is a reliable indicator of 
the sympathetic response to the CPT, and if it can be used on its own to measure such a response. 
While salivary α-amylase did infact increase upon the CPT, it was delayed as compared to the 
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sharp increase in hemodynamic and cardiovascular parameters. If salivary α-amylase was a 
accurate indicator of sympathetic activity then it would have been at its highest levels during the 
CPT, and drop to baseline during recovery. Thus, the change in systolic blood pressure remains 
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Note: All pictures in appendix 1 were retrieved from the Concordia University PODs: 
PC-POD-CP-007-v01 “Use and Cleaning of Nexfin”, August 2015 
PC-POD-CP-006-v01 “Use and Cleaning of HIC-4000I Impedance Cardiograph” August, 2015 
Methods 
1.0 Recruitment  
 
1.1 Recruitment of Participants  
 
Participants were recruited through Concordia University, social media, word-of-mouth and 
through the PERFROM Centre’s participant database. A flyer was posted on social media with 
general information regarding the study and participation requirements. A total of 16 males and 
16 females were recruited for the study. Collection of data took place between the months of May 
2015 and September 2015.  
 
1.2 Participants screening  
 
Participants who were interested in being part of the study had to meet certain preliminary 
criteria before being considered for the study. These criteria were included on the recruitment 
flyer. The flyer explained that the main component was the CPT. Only participants who were 
over the age of 18, were non-smokers, reported to be healthy (had no known disorders or 
diseases), and who were not taking any prescription medication to treat a disorder or disease were 
considered for participation. Before scheduling participants, they were told that in order to 
participate they would have to follow certain pre-participation instructions. They would have to 
refrain from exercising, consuming alcohol and caffeine at least 12 hours before the study day, 
and would have to not consume any food at least 2 hours before partaking in the study. They 
were also told that they would be setup with electrodes and blood pressure monitors and provide 
saliva samples throughout the study. Individuals who were confortable with all of these 
conditions were then scheduled for participation. 
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1.3 Participant Scheduling  
 
 Participants who met the preliminary criteria were asked to provide their availabilities for 
participation and were informed they would need to be available for a block of approximately 1.5 
hours. They were given the choice of choosing a day that best suited their schedules from 
Monday to Friday, in addition to a time from the following options: 9:30, 11:30,13:30, and 15:30. 
Female participants were scheduled based on availability and menstrual cycle. Females were 
asked to report when they last had their period, their study date was scheduled not more than 7 
days post their last period. Once scheduled for the study, participants were sent a list of 
instructions that were to be followed on the day prior to participation.  
 
1.4 Pre-Participation Instruction 
 
 Upon scheduling and on the day before participation, participants were sent e-mails with 
the instructions they needed to follow. The instructions were: 
 
On the eve of the study: 
1. Do not exercise at least 12 hours prior to participation 
2. Do not consume alcohol at least 12 hours prior to participation  
3. Do not consume caffeine at least 12 hours prior to participation  
 
On the day of the study:  
1. Do not eat at least 2 hours before participation. You may drink water.  
2. Do not chew gum at least 2 hours before participation.  
 
Attire (Females): 
1. Since we will be placing electrodes around your torso, please wear a sports bra. You will 
be in a closed room therefore only the researcher and any assistant will be in the vicinity.  
2. You may bring a short-sleeve button-down shirt to wear during the study.  
3. If possible, make sure that you have not applied any body lotion onto your neck or torso.  
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Attire (Males):  
1. Since we will be placing electrodes around your torso, you will be asked to remove your 
shirt. You will be in a closed room therefore only the researcher and any assistant will be 
in the vicinity.  
2. You may bring a short-sleeve button down shirt to wear during the study.  
3. If possible, make sure that you have not applied any body lotion onto your neck or torso.  
2.0 Study day 
 
2.1 Participant Instruction  
 
 Upon arrival to PERFORM, participants were assisted to the cardiopulmonary suite. They 
were asked to put their personal belongings away in an assigned locker with a lock. Participants 
were then walked through the consent form, reminded of the participation conditions, and shown 
the equipment they would be set-up with. Participants were then asked if all the pre-participation 
instructions were followed. Upon responding “yes”, the consent form was signed, the researcher 
filled out the information bheet (see Figure 1.), and participants were then ready for equipment 
set-up.  
3.0 Participant Measurements and Set-Up  
 
3.1 Weight Measurement  
 
 Participants were asked to remove their shoes and any heavy objects from their pockets. 
Weight was recorded in both Kg and pounds using the scale in the Cardiopulmonary Suite. This 
data was entered into a sheet since it was necessary for Nexfin
®





3.2 Height Measurement  
 
 Participants were asked to remove their shoes and then stand against the wall. They were 
asked to stand up straight, look straight ahead, and then take a deep breath in. At the end of the 
inhalation, height was marked on the wall. Height measures were taken in cm. This data was 
entered into the information worksheet since it was necessary for Nexfin
®
 and COP_WIN™ 
software. 
 
3.3 ECG-Setup- Attachment of Band Impedance Electrodes  
  
The impedance cardiograph that was used in this study was the HIC-4000I
®
 (Bio-Impedance 
Technology, Inc., Chapel Hill, NC). The impedance cardiograph was used to measure heart rate 
(HR), stroke volume (SV), cardiac output (CO), pre-ejection period (PEP), left ventricular 
ejection time (LVET), PEP/LVET, and peak ejection velocity (dZ/dtmax). Participants were set 
up with disposable mylar band electrodes (T8001 Bio-Impedance Technology, Inc., Chapel Hill, 
NC) while they were standing.  
The following steps were used for participant set-up:  
3.3.1 Using a measuring tape, the circumference of the upper limit of the participant’s neck 
was measured adding 3-4 inches at each end. The measuring tape was put against the 
electrode tape and was cut. This was band #1.  
3.3.2 3 cm was measured from the lower edge of the conductive part of the electrode band 
and the location was marked.  
3.3.3 3 cm was measured from the lower edge of the conductive part of the electrode band 
and the location was marked.  
3.3.4 Using a measuring tape, the circumference of the neck at the marked location was 
measured adding 3-4 inches at each end. The measuring tape was put against the 
electrode tape and was cut. This was band #2.  
3.3.5 Using a measuring tape, the circumference of the trunk directly under the break line 
(at the Xyphoid process) was measured adding 3-4 inches at each end. The measuring 
tape was put against the electrode tape and was cut. This was band #3.  
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3.3.6 3 cm was measured from the lower edge of the conductive part of the electrode band 
and the location was marked.  
3.3.7 Using a measuring tape, the circumference of the neck at the marked location was 
measured adding 3-4 inches at each end. The measuring tape was put against the 
electrode tape and was cut. This was band # 4. 
3.3.8 The protective backing of the electrode tape was removed and the bands were placed 
in the appropriate locations staring from the anterior mid-line of the participant’s 
body, making sure to not apply the bands too tightly, leaving slack, making way back 
to the midline on the opposite side of the body.  
3.3.9 Once back at the mid-line, the participant was asked to inhale deeply, then the two 
ends of the tape were joined, making sure they were not connected too tightly. 
3.3.10 The ends of the tape were then folded back onto each other, leaving no free tape at the 
connected ends.  
3.3.11 The distance in (cm) between the lower edge of the conductive portion of band #2 and 
the upper edge of the conductive portion of band #3 in both the anterior and posterior 
of the participant was measured and noted in the dialogue box. 
3.3.12 The appropriately numbered electrode clips of the impedance cardiograph machine 
were then connected to the folded back ends of the electrode bands.  
3.3.13 The wires were taped down using surgical tape to secure the wires limiting pulling 
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device was used in addition to the Nexfin
® 
to obtain blood pressure readings (systolic blood 
pressure (SBP) and diastolic blood pressure (DBP)), and HR at several time points during the 
study. Unlike the Nexfin
®
, this device does not collect continuous readings. The start button 
was pressed manually to initiate a reading at the desired time-point. The button was pressed 
45 seconds prior to the time point to ensure the machine had enough time for blood pressure 
and heart rate measurement.  
 
The following steps were used for participant set-up: 
 
3.4.1 The appropriate cuff size for the participant’s arm was selected. This was done by 
wrapping the cuff around the participant’s upper arm, making sure that the arm’s 
circumference fell within the cuff’s “RANGE” arrows.  
3.4.2 The brachial artery was palpated. 
 
 
3.4.3 The cuff was then put onto the participant, making sure that the artery of the cuff was 
pointing down the arm, and that the lower edge of the cuff was 3-5cm above the 
antecubital fossa.  
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3.4.4 The cuff was then wrapped around the arm and the Velcro was secured.  
3.4.5 Before taking any blood pressure reading using this device, it was ensured that there 
was a stable heart rate reading on the monitor.  
 




 is a monitoring system used to monitor continuous non-invasive blood 
pressure and was used to measure trend beat-to-beat hemodynamic parameters, including 
SBP, DBP, mean arterial pressure (MAP), SV, CO, systemic vascular resistance (SVR) and 
HR. Nexfin
®
 uses a single finger sensor to make necessary measurements. 
 
Before setting participants up with the Nexfin
®
, they were instructed of the following:  
 
- Refrain from talking during measurements since this can significantly affect blood 
pressure. 
- Keep legs uncrossed. 
- Keep the measurement arm relaxed and do not overstretch the hand. 
- Avoid unnecessary movement of the fingers.  
- Avoid pressing the measurement arm down; this can cause obstruction of blood flow to 
the hand.  
- Slight pulsation in the finger where the cuff is applied will occur and this is normal.  
- During measurement the distal part of the finger inserted in the cuff might become red. 
This is normal and coloring will go back to normal after cuff is removed.  
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The following steps were used for participant set-up 
 
3.5.1 For all participants, the middle finger was chosen as the measurement finger.  
3.5.2 An appropriate finger cuff size was selected (small, medium, large). When selecting 
the appropriate size, the finger fits exactly between the optical components on the 
finger cuff and the air bladder inside the finger cuff fully encloses the middle phalanx 
of the finger when the cuff is tightly wrapped around the finger.  
3.5.3 The finger cuff was placed on the finger making sure that the cuff was centered 









3.5.4 The finger was placed between the two optical components.  
 
 
3.5.5 The cuff cable and that of the air hose were gently led between two fingers to the back 




3.5.6 The cuff was tightly wrapped following the contour of the finger, making sure that the 
cuff could not be twisted or shifted. 
 
 
3.5.7 The cable with the silver outlet was then connected making sure that the red dot on the 
connector was aligned with the one on the receptacle. The air hose was then connected 
to the air outlet.  
 
3.5.8 The heart reference box of the heart reference complex was then attached to the 
participant at heart level. For female participants, it was clipped onto the sports bra at 
heart level. For male participants, the box was taped to their chests at heart level, 
using surgical tape.  
3.5.9 A foam finger strap was then wrapped around the middle phalanx of an adjacent 
finger on which the finger strap is attached, with the Velcro on the outside. 
3.5.10 The finger side of the heart reference system (HRS) was then attached onto the Velcro 
finger strap at the same level as the finger cuff.  
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3.5.11 The HRS connector was then connected to the black connector receptacle on the wrist 
unit labeled “HRS”, making sure that the red dot on the connector is aligned with the 
one on the receptacle.  
 
4.0 Calibration  
 
 Once participants were set up with the two devices, each was calibrated. It was necessary 
to first set the participants up before calibrating, since both devices need to calibrate according to 











 was calibrated using the COP_WIN™ software and buttons on the 
machine.  
 
4.1.1  In the main menu, “Calibration” was selected. 
4.1.2  “Calibrate COP_WIN System” was then selected, opening the “System Calibration” 
window. 
4.1.3 On the HIC-4000I
®, the “BL” button on the keypad was then selected.  





4.1.5 On the HIC-4000I
®, the “CAL” key on the keypad was then selected.  
4.1.6 After two or three cycles of the dZ/Dt calibration signal (a square wave) appeared 











Calibration – Zeroing of HRS  
 
 The HRS needed to be zeroed before measurement since it is important to know where the 
finger is in relation to the heart when measuring beat per beat heart rate and blood pressure.  
 










4.2.2 Participant information (sex, age, weight (kg) and height (cm)) was entered followed by 
“Accept”. 
4.2.3 The tab was selected. 




4.2.5 When aligned the HRS was made equal to 0 mmHg. Once at 0, the “Zero HRS” button on 
the control bar was selected. 
4.2.6 The “Next” button was selected on the window that appears. 
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4.2.7 The “Zero!” button was selected in order to start the zeroing procedure, while both 
endings of the heart reference system we kept at the same level until the message “HRS 
zeroed!” displayed. 








5.0 Data Acquisition  
  
All data saved on the COP_WIN™ software and Nexfin® was coded with each 
participant’s assigned code.  
 
The COP_WIN™ software was set up to collect data continuously, using 30second 
ensemble averages (EA), with a 60Hz filter applied.   
 
Before starting data acquisition, the Nexfin
®
 was started in order for the physiosocial to 
reach >30. Once physiosocial was >30, the time was noted and the Impedance Cardiograph was 
started. The time point where recording started by clicking “sample” in the COP_WIN™ 
software was started was taken as time = 0 minutes (t0). The researcher kept a timer in order to 
make sure all samples were collected at the correct and desired time.  
 
5.1 Participant instruction during data acquisition  
 
Participants were reminded that they would now sit for 15 minutes before the CPT for 
baseline parameter collection. They were reminded to sit still and avoid clenching of the hands, 




 Figure 1. is the schematic of the study. At time point t0, the participants had been set-up 
with all of the equipment and measurement is initiated at t0. After the Nexfin
®
 was calibrated, the 
“Start” button was selected in the COP_WIN™ software, and the timer was started. At the 





. The values were noted in an information worksheet. While the blood 
pressure was being read, the assistant to the researcher collected the saliva sample from the 
participant. Participants were asked to have the saliva pool in their mouths 2.5 minutes prior to 
collection during baseline. The sample was collected using an individually sealed sterile transfer 
pipette and transferred into a 1.5ml micro-centrifuge tube. After the third baseline measure was 
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collected (t3), a 2minute window was allotted to give the researcher time to retrieve the cooler 
containing the ice cold water and position it next to the participant. A towel was placed on the 
participants lap in preparation for when the hand would be removed from the water. Participants 
were reminded that they could withdraw their hands from the cold water at any time and would 
not be penalized for having done so, and would unconditionally be compensated for their 
participation.  
 
At the end of the 2minute window, the participants were instructed to submerge their 
hand into the water bath up to wrist level for 5 minutes. They were advised to not clench their 
hands, rather keep it in a passive open position. 2.5 minutes into the CPT (t4) and at the end of the 





 and saliva samples were collected. The participant’s hand was removed from the cold 
water and wrapped in the towel to warm it back up. They were now asked to rate the pain they 
had felt on a scales of 0 to 10 using a visual analog scale (0= no pain to 10= most painful) at three 
different time points; 10 seconds after they had submerged their hand in the cold water, halfway 
through the CPT (t4) and right before they took their hand out of the cold water (t5).  
 
Blood pressure, HR measures, and saliva samples were collected 5minutes (t6) after the 


























 What time did you wake up: 
How was the quality of your sleep?: 
How did you get here? 
How long ago did you last eat? 
 






5.3 Saliva Analysis  
  
Saliva was collected using sterile transfer pipettes and samples were transferred and 
stored in 1.5ml micro-centrifuge tubes until needed. Participants were asked to have saliva pool 
in their mouths between their tongue and pallet instead of actively salivating, to ensure that they 
were not stimulating the secretion of salivary α-amylase. Saliva was collected at all time points 
using a sealed sterile transfer pipette which was inserted between the tongue and palette 
collecting the accumulated saliva. Collecting saliva passively is as effective as a salivette, the 
gold standard for saliva collection (Rohleder et al, 2006; Granger et al, 2006). Roughly 0.5ml of 
saliva was collected from each participant. Saliva was weighed and divided into 20μl labeled 
aliquots before being frozen at -20°C until needed for analysis.  
 Before analyzing the samples, they were thawed and centrifuged at 1500 x g for 15 
minutes. Samples were analyzed for salivary α-amylase using an α-amylase kinetic reaction kit 
(1-1902, (Single) 96-Well Kit, Salimetrics Inc, Carlsbad, CA). The protocol provided by the 
manufacturer was followed. Before analyzing the saliva it had to be diluted. A 1:10 dilution was 
made by mixing 10μl of each saliva sample with 90μl of diluent. The sample was further diluted 
to a 1:200 dilution by adding 10μl of the 1:10 to 190μl of diluent. 8μl of the pre-diluted controls 
(high and low SAA) and the 1:200 saliva dilutions were plated on a 96-well plate. Samples were 
plated in duplicate. 300μl of α-amylase substrate pre-heated at 37°C was added to the plate, one 
row at a time and was read through a 405nm filter. Readings were taken at 1 and 3 minutes, time 
point 3 was subtracted from time point 1 and multiplied by 328 to get the activity measure in 
Units per milliliters (U/ml). Samples that were not contaminated with blood were discarded 
following CL1 procedures.  
6.0 Data Cleaning 
 









, the data was cleaned and binned in order to represent the 7 specific time points 









 Data Cleaning  
 




 was not altered since it only provided 1 
measure for blood pressure (SBP and DBP) at each of the 7 times points. This device provided 








 was used to collect cardiovascular and hemodynamic data continuously from the 
beginning to the end of the study. The report that was provided from the Nexfin
®
 machine 
provided an averaged value for every 30 seconds of time for the 32 minute duration of the study. 
These values were averaged to get a value that corresponded to each of the 7 time points.  
 
The data was binned in the following way: 
 
First 5 minutes of baseline averaged = t1 
Seconds 5 minutes baseline averaged = t2 
Third 5 minutes of baseline averaged = t3 
Two minutes wait period before the CPT= deleted  
First 2.5 minutes of CPT averaged= t4 
Last 2.5 minutes of CPT averaged = t5 
First 5 minutes of Recovery= t6 
Last 5 minutes of Recovery= t7 
 
 The data collected from the Nexfin
®
 was included for 29 of the 30 participants. No data 
was recorded for LCR69, a female participant since the participant’s hands were cold too cold. 
Nexfin
®
 does not pick up information about the pulse pressure if the hands are cold. This device 





6.3 HIC-4000I Impedance Cardiograph Data Cleaning   
 
 The impedance cardiograph HIC-4000I was used to collect data continuously from the 
beginning to the end of the study. Before creating reports for each of the participants, the data 
was manually cleaned by adjusting the B-wave point using the B-cursor edit tool option in the 
COP_WIN™ software. In some cases the B-point had to be shifted manually to the beginning 
point of the rapid upslope of the dZ/dt waveform as it climbs to reach the peak because the 
original recording had not identified it correctly. Once every file was cleaned, the data was 
averaged in the same way as the data from the Nexfin
®
. 30second ensemble averages (EA) were 
used, therefore data was present for every 30 second EA.  
The data was binned in the following way: 
 
First 5 minutes of baseline averaged = t1 
Seconds 5 minutes baseline averaged = t2 
Third 5 minutes of baseline averaged = t3 
Two minutes wait period before the CPT= deleted  
First 2.5 minutes of CPT averaged= t4 
Last 2.5 minutes of CPT averaged = t5 
First 5 minutes of Recovery= t6 
Last 5 minutes of Recovery= t7 
 
 The data collected from the impedance cardiograph HIC-4000I was included for 27 of the 
30 participants. LCR58 (Female), LCR79 (Female), and LCR 87 (Male) were excluded since 
there was a technical issue with the software and the data was not recorded. This device provided 
information about HR, PEP, LVET, PEP, LVET, CO, and SV. TPR was calculated using a 
standard formula (Bacon et al., 2006; Sherwood et al., 1990).  
7.0 Statistical Analyses 
 
 Once all data was cleaned, a master excel sheet was created with all values from all 30 
participants including their general characteristics and all binned data collected from all three 
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pieces of equipment for the 7 times points in addition to salivary α-amylase data. When doing 
any of the comparisons, baseline was defined as the average of the value in question at t1, t2, and 
t3. CPT was defined as the average of t4 and t5. Recovery was the average of t5 and t6. The 
standard deviations for mean baseline, CPT, and recovery were also computed in order to 




 An un-paired two-tailed t-test was used to compare all baseline measures between men 
and women using GraphPad Prism. A paired two-tailed t-test was used to compare mean 
baseline, CPT, and recovery values. A 95% confidence interval was used for all t-tests; they were 
all computed using GraphPad Prism.  
 
7.2 Delta Values (Δ1 and Δ2)  
 
 Once mean baseline, CPT, and recovery were computes for salivary α-amylase, and all 
hemodynamic and cardiovascular parameters, Δ1 and Δ2 were calculated. Δ1 was the mean CPT 
– mean baseline and Δ2 was meaning CPT – mean recovery. All delta calculations were done on 
excel using the master data sheet.  
 
7.3 Spearman’s Correlation Coefficient  
 
 Spearman’s correlation coefficient was used to measure statistical dependence between 
two variables. Salivary α-amylase levels at baseline, CPT, recovery, in addition to the delta 
values were correlated to cardiovascular and hemodynamic parameters that are thought to reflect 
sympathetic activity. A 95% confidence interval was used. The table shows the ρ-value in 






7.4 Repeated Measures ANOVA 
A repeated measures one way ANOVA was used to determine if there was a significant 
difference in α-amylase levels and the cardiovascular and hemodynamic parameters measured at 
three different periods; baseline (average t1,t2,t3), CPT (average t4,t5) and recovery (average t5,t6). 
A p-value <0.05 was used for the analysis (GraphPad Prism, version 5.01 for windows, Graphpad 
Software, Inc. 2007). Tukey’s post hoc test was used to determine which of the three groups were 




 All graphs were made using GraphPad Prism (GraphPad Prism, version 5.01 for 
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Note: Pain 1= 10 seconds into CPT, pain 2= midway through CPT, pain 3= end of CPT 




Male 39 180 83.6 Canadian 3 LCR	2 5 3 4
Female 26 161 80.5 Colombian 1 LCR	8 3 7 9
Male 30 181 135 Italian 4 LCR	54 5 10 10
Male 27 183.5 99.4 Greek 3 LCR	55 7 6 4
Male 28 174.5 85.5 Italian 3 LCR	56 2 6 10
Male 26 180.5 73 Meritian 3 LCR	57 8 6 8
Male 26 163.5 74.5 Italian 4 LCR	58 8 9 9
Female 27 167 78.5 ital/leb 4 LCR	59 5 9 8
Male 26 175.5 74.3 Dominican 2 LCR	60 8 6 8
Female 24 163 56 ital/leb 3 LCR	62 5 6 6
Female 24 167 56 Canadian 1 LCR	63 8 5 3
Male 25 175 84 Greek/Polish 4 LCR	64 6 3 5
Female 22 170.5 86.1 Latina 4 LCR	65 2 5 9
Female 19 164 66.6 Canadian 3 LCR	67 8 6 6
Female 25 171 79.5 Greek/Jamaican 3 LCR	68 8 6 4
Female 22 166.5 47 African 4 LCR	69 8 6 4
Female 22 170 67.5 Canadian 4 LCR	70 3 4 5
Female 23 171 72.4 Haitian/Romanian 4 LCR	71 8 9 7
Female 19 171 55.8 African 3 LCR	72 10 7 6
Male 23 180.5 73.9 Italian 4 LCR	76	 5 4 2
Female 20 161 50.7 Bingladi 3 LCR	77 9 8 5
Female 22 167.5 72.5 Italian 3 LCR	78 8 5 4
Female 25 155 62 Canadian 2.5 LCR	79 8 10 8
Female 23 159.5 53.7 Russian	 4 LCR	80 9 1 1
Female 18 150 56 Canadian	 3 LCR	82 8 5 2
Male 29 174 81.8 Irish	 3 LCR	83 5 6 8
Male 23 160 67.2 ital/leb 4 LCR	84 3 5 2
Male 39 177 83 Italian	 4 LCR	85 6 4 3
Male 20 188 80 Persian 4 LCR	86 6 4 3
Male 20 176 67 Italian	 4 LCR	87 7 5 3
